Complete Filing Data
Cyngn Inc. reported Stockholders Equity of $38.75 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Cyngn Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$23.5M | -$33.3M | -$22.8M | -$19.2M | -$7.8M | -$8.3M |
| Research And Development Expense | $12.5M | $11.3M | $12.7M | $9.5M | $5.0M | $5.1M |
| Operating Income Loss | -$25.7M | -$22.8M | -$23.3M | -$19.4M | -$9.4M | -$8.4M |
| Nonoperating Income Expense | $2.2M | -$10.5M | $534.7K | $164.2K | $1.6M | $34.8K |
| General And Administrative Expense | $13.3M | $11.4M | $10.9M | $10.0M | $4.4M | $3.3M |
| Interest Income Expense Net | $137.9K | $44.1K | -$9.6K | $39.8K | ||
| Revenues | $219.0K | $368.1K | $1.5M | $262.0K | ||
| Cost Of Revenue | $135.7K | $535.7K | $1.2M | $186.8K | ||
| Other Nonoperating Income Expense | $884.9K | $53.1K | $396.8K | |||
| Interest Income Expense Nonoperating Net | $197.4K | -$1.1M | $137.9K | |||
| Operating Expenses | $9.4M | $8.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$8.4M | -$5.4M | -$7.6M | -$5.4M | -$5.8M | -$6.0M | -$5.5M | -$6.4M | -$5.6M | -$5.3M | -$4.6M | -$3.8M | -$2.1M | -$2.1M | -$1.6M | -$2.3M | -$1.8M | -$2.1M | -$2.2M |
| Research And Development Expense | $5.3M | $2.0M | $2.1M | $2.8M | $3.2M | $3.2M | $2.9M | $3.7M | $3.0M | $2.7M | $2.3M | $1.7M | $1.2M | $831.9K | $934.3K | $1.5M | |||
| Operating Income Loss | -$8.4M | -$5.5M | -$5.2M | -$5.5M | -$5.8M | -$6.0M | -$5.6M | -$6.5M | -$5.8M | -$5.3M | -$4.6M | -$3.8M | -$2.1M | -$2.1M | -$1.5M | -$1.8M | |||
| Nonoperating Income Expense | -$21.6K | $53.6K | -$2.4M | $80.8K | -$6.7K | -$3.7K | $138.2K | $142.0K | $216.1K | $19.0K | $952.00 | -$378.00 | $25.9K | $2.1K | -$2.1K | $2.1K | |||
| General And Administrative Expense | $3.2M | $3.5M | $3.1M | $2.6M | $2.6M | $2.7M | $2.7M | $2.8M | $3.1M | $2.6M | $2.4M | $2.1M | $973.9K | $1.3M | $615.4K | $267.3K | |||
| Interest Income Expense Net | -$1.7K | $32.9K | $18.9K | $46.9K | $4.7K | -$1.6K | -$379.00 | -$4.0K | -$3.9K | -$2.1K | $1.6K | ||||||||
| Revenues | $70.0K | $33.7K | $47.2K | $47.6K | $8.7K | $5.5K | $25.2K | $551.0K | $872.8K | ||||||||||
| Cost Of Revenue | $50.8K | $16.9K | $11.8K | $157.3K | $14.9K | $113.8K | $42.4K | $462.6K | $616.7K | ||||||||||
| Other Nonoperating Income Expense | $230.9K | $251.5K | $91.9K | $34.5K | -$5.1K | -$5.0K | $105.3K | $123.1K | $169.2K | ||||||||||
| Interest Income Expense Nonoperating Net | -$252.5K | -$198.0K | $74.8K | $46.3K | -$1.7K | $1.3K | $32.9K | ||||||||||||
| Operating Expenses | $5.3M | $4.6M | $3.8M | $2.1M | $2.1M | $1.5M | $1.8M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $38.8M | -$1.0M | $10.6M | $24.1M | $22.2M | $5.6M | $13.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $990.0K | $23.6M | $3.6M | $10.6M | $22.0M | $6.5M | $13.7M |
| Retained Earnings Accumulated Deficit | -$216.8M | -$193.4M | -$160.0M | -$135.7M | -$116.5M | -$108.7M | |
| Property Plant And Equipment Net | $3.3M | $2.3M | $1.5M | $884.0K | $102.8K | $133.8K | |
| Prepaid Expense And Other Assets Current | $1.5M | $592.1K | $1.3M | $1.1M | $525.3K | $48.9K | |
| Liabilities And Stockholders Equity | $50.1M | $30.1M | $13.0M | $25.5M | $22.7M | $6.7M | |
| Assets Current | $39.8M | $25.6M | $9.5M | $23.8M | $22.5M | $6.5M | |
| Assets | $50.1M | $30.1M | $13.0M | $25.5M | $22.7M | $6.7M | |
| Accounts Payable Current | $217.4K | $247.8K | $197.0K | $155.9K | $112.3K | $73.0K | |
| Liabilities | $11.3M | $31.1M | $2.4M | $1.4M | $407.4K | $1.1M | |
| Common Stock Value | $80.00 | $2.00 | $337.00 | $265.00 | $10.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$22.6M | $20.0M | -$7.0M | -$11.4M | $15.5M | -$7.2M | |
| Accounts Payable And Other Accrued Liabilities Current | $2.6M | $2.1M | $1.2M | $854.9K | $295.2K | $307.4K | |
| Liabilities Current | $4.8M | $3.4M | $2.1M | $1.4M | $407.4K | $380.4K | |
| Cash And Cash Equivalents At Carrying Value | $990.0K | $23.6M | $10.5M | $21.9M | $6.1M | ||
| Intangible Assets Net Excluding Goodwill | $1.9M | $1.1M | $473.1K | $30.9K | $34.4K | ||
| Operating Lease Liability Current | $312.4K | $317.3K | $682.7K | $376.6K | |||
| Short Term Investments | $33.7M | $4.6M | $12.1M | ||||
| Operating Lease Right Of Use Asset | $6.0M | $297.9K | $992.3K | $371.2K | |||
| Restricted Cash Current | $50.0K | $400.0K | |||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $2.0M | $1.2M | |||||
| Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses | $1.9K | ||||||
| Unrealized Gain Loss On Investments | $443.4K | $90.2K | |||||
| Operating Lease Liability Noncurrent | $6.5M | $317.3K | |||||
| Finance Lease Right Of Use Asset | |||||||
| Gain Loss On Sale Of Other Assets | -$16.6K | $31.4K | |||||
| Finite Lived Intangible Assets Net | $466.2K | $1.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $38.7M | $46.8M | $22.1M | $6.6M | $9.7M | $8.0M | $10.2M | $13.9M | $19.4M | $28.8M | $33.3M | $19.0M | $29.7K | $2.1M | $4.1M | $7.9M | $9.6M | $11.7M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.8M | $31.3M | $1.0M | $2.0M | $5.9M | $2.2M | $3.5M | $3.1M | $8.0M | $5.7M | $5.7M | $18.5M | $1.7M | $3.8M | $5.6M | |||||
| Retained Earnings Accumulated Deficit | -$211.2M | -$202.3M | -$196.9M | -$177.2M | -$171.8M | -$166.0M | -$153.2M | -$147.7M | -$141.4M | -$130.2M | -$124.9M | -$120.3M | -$114.4M | |||||||
| Property Plant And Equipment Net | $3.0M | $2.6M | $2.4M | $2.1M | $2.0M | $1.7M | $1.4M | $1.2M | $1.3M | $654.6K | $467.7K | $308.6K | $70.2K | |||||||
| Prepaid Expense And Other Assets Current | $4.2M | $4.4M | $2.4M | $1.7M | $1.3M | $1.5M | $436.9K | $1.1M | $1.4M | $536.8K | $603.5K | $509.4K | $317.8K | |||||||
| Liabilities And Stockholders Equity | $49.3M | $56.2M | $24.3M | $8.5M | $11.9M | $9.8M | $11.6M | $15.6M | $20.3M | $29.7M | $34.5M | $20.1M | $2.1M | |||||||
| Assets Current | $39.1M | $43.6M | $18.7M | $4.5M | $8.3M | $6.3M | $8.6M | $13.3M | $18.3M | $28.2M | $33.3M | $19.0M | $2.0M | |||||||
| Assets | $49.3M | $56.2M | $24.3M | $8.5M | $11.9M | $9.8M | $11.6M | $15.6M | $20.3M | $29.7M | $34.5M | $20.1M | $2.1M | |||||||
| Accounts Payable Current | $360.4K | $176.3K | $281.7K | $190.5K | $180.2K | $248.7K | $234.4K | $305.4K | $443.6K | $299.1K | $243.5K | $94.7K | $269.2K | |||||||
| Liabilities | $10.6M | $9.4M | $2.2M | $1.8M | $2.2M | $1.8M | $1.3M | $1.6M | $913.9K | $1.3M | $1.0M | $2.1M | ||||||||
| Common Stock Value | $70.00 | $70.00 | $18.00 | $20.00 | $18.00 | $884.00 | $8.00 | $352.00 | $338.00 | $337.00 | $337.00 | $336.00 | $271.00 | $10.00 | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$22.6M | -$1.4M | -$2.6M | -$3.5M | -$813.3K | |||||||||||||||
| Accounts Payable And Other Accrued Liabilities Current | $3.5M | $1.1M | $1.4M | $720.2K | $700.0K | $751.2K | $231.7K | $135.0K | $386.6K | $173.0K | $218.6K | |||||||||
| Liabilities Current | $3.9M | $3.0M | $2.2M | $1.8M | $2.2M | $1.7M | $945.7K | $1.1M | $816.6K | $487.8K | ||||||||||
| Cash And Cash Equivalents At Carrying Value | $4.8M | $31.3M | $1.0M | $5.9M | $2.2M | $3.6M | $3.5M | $3.1M | $8.0M | $5.6M | $5.6M | $18.3M | $1.7M | |||||||
| Intangible Assets Net Excluding Goodwill | $1.5M | $986.1K | $1.0M | $1.2M | $556.8K | $509.3K | $364.4K | $181.9K | $30.1K | $31.8K | ||||||||||
| Operating Lease Liability Current | $37.0K | $202.6K | $127.6K | $505.2K | $691.3K | $724.7K | $413.4K | $557.1K | $238.6K | $511.7K | $455.5K | $549.0K | ||||||||
| Short Term Investments | $30.1M | $7.9M | $15.3M | $812.8K | $1.1M | $2.6M | $4.6M | $9.1M | $9.0M | $22.0M | $27.0M | |||||||||
| Operating Lease Right Of Use Asset | $6.2M | $6.4M | $119.8K | $474.1K | $648.5K | $821.1K | ||||||||||||||
| Restricted Cash Current | $50.0K | $50.0K | $50.0K | $126.5K | $50.0K | |||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $824.3K | |||||||||||||||||||
| Acquisition Of Property And Equipment Included In Accounts Payable And Accrued Expenses | $17.4K | $27.6K | $139.6K | |||||||||||||||||
| Unrealized Gain Loss On Investments | $39.9K | $169.2K | ||||||||||||||||||
| Operating Lease Liability Noncurrent | $6.7M | $6.4M | $127.6K | $189.8K | $228.7K | |||||||||||||||
| Finance Lease Right Of Use Asset | $404.9K | $553.9K | $233.2K | $371.2K | $507.9K | $643.2K | $777.2K | |||||||||||||
| Gain Loss On Sale Of Other Assets | -$52.7K | |||||||||||||||||||
| Finite Lived Intangible Assets Net | $470.8K | $3.1M | $2.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $1.6M | $2.4M | $3.2M | $2.9M | $1.1M | $131.7K |
| Net Cash Provided By Used In Operating Activities | -$23.6M | -$19.2M | -$19.5M | -$16.3M | -$8.6M | -$7.9M |
| Net Cash Provided By Used In Financing Activities | $35.1M | $36.3M | $6.1M | $18.2M | $24.2M | $695.7K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $1.4M | $44.0K | $1.4M | $1.4M | $476.5K | -$33.8K |
| Depreciation Depletion And Amortization | $1.2M | $669.4K | $961.3K | $604.9K | $85.9K | $159.0K |
| Increase Decrease In Accounts Payable | -$30.3K | $50.8K | $41.0K | $43.7K | $39.3K | -$43.3K |
| Net Cash Provided By Used In Investing Activities | -$34.1M | $2.9M | $6.4M | -$13.3M | -$20.0K | |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $411.6K | $1.7M | $969.7K | $936.4K | $3.5K | $137.5K |
| Stock Issued During Period Value Share Based Compensation | $2.9M | $1.1M | $131.7K | |||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $1.6M | $2.4M | $9.8M | |||
| Proceeds From Stock Options Exercised | $8.5K | $114.2K | $14.2K | $623.00 | ||
| Payments To Acquire Intangible Assets | $29.1K | $954.2K | $718.7K | $456.8K | ||
| Payments To Acquire Property Plant And Equipment | $1.2M | $1.1M | $1.0M | $918.3K | ||
| Payments To Acquire Short Term Investments | $87.4M | $7.6M | $21.6M | |||
| Proceeds From Issuance Initial Public Offering | $1.9M | $4.4M | $18.1M | $23.3M | ||
| Payments To Acquire Equity Method Investments | $918.3K | $62.2K | ||||
| Proceeds From Debt Net Of Issuance Costs | $138.6K | $21.2K | ||||
| Proceeds From Sale And Maturity Of Marketable Securities | $29.5M | $15.0M | ||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $54.5M | $12.2M | $29.5M | |||
| Payments To Acquire Investments | $21.6M | $27.0M | ||||
| Proceeds From Atthemarket Equity Financing Net Of Issuance Costs | $5.5M | $6.8M | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $536.2K | $654.0K | $924.9K | $520.1K | $7.9K | |||||||||||||
| Net Cash Provided By Used In Operating Activities | -$6.5M | -$5.8M | -$5.4M | -$3.4M | -$1.7M | |||||||||||||
| Net Cash Provided By Used In Financing Activities | -$1.0K | $2.7M | $6.8K | $88.9K | $899.8K | |||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $941.5K | $185.7K | $258.9K | $808.4K | $1.9K | |||||||||||||
| Depreciation Depletion And Amortization | $240.9K | $225.6K | $228.0K | $69.1K | $22.9K | |||||||||||||
| Increase Decrease In Accounts Payable | $33.9K | $51.7K | $287.7K | -$17.6K | -$72.4K | |||||||||||||
| Net Cash Provided By Used In Investing Activities | -$16.1M | $1.8M | $2.8M | -$226.9K | -$1.7K | |||||||||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.3M | -$628.7K | -$761.2K | $655.5K | -$116.0K | |||||||||||||
| Stock Issued During Period Value Share Based Compensation | $873.7K | $924.9K | $757.1K | $713.6K | $520.1K | $70.4K | $88.2K | $7.9K | $1.2K | $1.6K | $128.9K | |||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $354.9K | $456.9K | $536.2K | $601.8K | $615.7K | $654.0K | $719.3K | $873.7K | $924.9K | |||||||||
| Proceeds From Stock Options Exercised | $6.8K | $88.9K | ||||||||||||||||
| Payments To Acquire Intangible Assets | $655.6K | $19.6K | $44.7K | |||||||||||||||
| Payments To Acquire Property Plant And Equipment | $178.5K | $214.2K | $447.7K | |||||||||||||||
| Payments To Acquire Short Term Investments | $23.0M | $1.8M | $10.5M | |||||||||||||||
| Proceeds From Issuance Initial Public Offering | -$53.00 | $899.8K | ||||||||||||||||
| Payments To Acquire Equity Method Investments | $447.7K | $226.9K | $1.7K | |||||||||||||||
| Proceeds From Debt Net Of Issuance Costs | $36.2K | $2.7M | $21.2K | |||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $3.8M | $13.7M | ||||||||||||||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $7.7M | $3.8M | ||||||||||||||||
| Payments To Acquire Investments | $10.5M | |||||||||||||||||
| Proceeds From Atthemarket Equity Financing Net Of Issuance Costs | $2.7M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.17 | -$2.5K | -$6.5K | -$0.55 | -$1.33 | -$8.78 |
| Earnings Per Share Basic | $-5.17 | $-2,521.41 | $-6,528.92 | $-0.55 | $-1.33 | |
| Weighted Average Number Of Shares Outstanding Basic | 4.5M | 13.2K | 3.5K | 34.9M | 5.9M | |
| Weighted Average Number Of Diluted Shares Outstanding | 4.5M | 13.2K | 3.5K | 34.9M | 5.9M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 8.0M | 199.1K | 5.1K | 33.7M | 26.5M | 951.8K |
| Common Stock Shares Issued | 8.0M | 199.1K | 5.1K | 33.7M | 26.5M | 951.8K |
| Common Stock Shares Authorized | 400.0M | 200.0M | 200.0M | 200.0M | 100.0M | 42.0M |
| Preferred Stock Shares Authorized | ||||||
| Preferred Stock Par Or Stated Value Per Share |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.20 | -$2.70 | -$6.60 | -$408.30 | -$610.85 | -$422.87 | -$11.03 | -$12.97 | -$0.15 | -$0.14 | -$0.15 | -$0.14 | -$2.17 | -$2.20 | -$1.85 | |||||
| Earnings Per Share Basic | $-1.20 | $-2.70 | $-6.60 | $-408.30 | $-610.85 | $-422.87 | $-11.03 | $-12.97 | $-0.15 | $-0.14 | $-0.15 | $-0.14 | $-2.17 | $-2.20 | $-1.63 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 7.0M | 2.0M | 1.2M | 13.3K | 9.5K | 14.1K | 496.0K | 489.9K | 37.7M | 37.0M | 30.7M | 26.9M | 966.2K | 951.8K | 951.8K | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 7.0M | 2.0M | 1.2M | 13.3K | 9.5K | 14.1K | 496.0K | 489.9K | 37.7M | 37.0M | 30.7M | 26.9M | 966.2K | 951.8K | ||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Outstanding | 7.0M | 7.0M | 1.8M | 2.0M | 1.8M | 88.5M | 35.2M | 33.8M | 33.7M | 33.7M | 33.6M | 27.1M | 966.2K | |||||||
| Common Stock Shares Issued | 7.0M | 7.0M | 1.8M | 2.0M | 1.8M | 88.5M | 35.2M | 33.8M | 33.7M | 33.7M | 33.6M | 27.1M | 966.2K | |||||||
| Common Stock Shares Authorized | 400.0M | 400.0M | 200.0M | 200.0M | 200.0M | 200.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 100.0M | 42.0M | |||||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.00 | 10.0M | 10.0M | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 22.0M | 22.0M | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Costs And Expenses | $25.9M | $23.2M | $24.8M | $19.7M | $9.4M | |
| Additional Paid In Capital | $170.7M | $159.8M | $138.7M | $114.3M | ||
| Other Income | $396.8K | $120.1K | $7.2K | -$5.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $114.2K | $14.2K | $623.00 | |||
| Stock Issued During Period Value Other | $5.5M | $6.8M | $1.7M | $23.1M | ||
| Stock Issued During Period Value Restricted Stock Award Gross | $597.00 | $8.5K | ||||
| Stock Issued During Period Value New Issues | $18.9M | $3.0M | ||||
| Realized Investment Gains Losses | $85.1K | $113.1K | $443.4K | |||
| Warrants And Rights Outstanding | $27.7M | |||||
| Stock Issued During Period Shares New Issues | 192.5K | 20.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q3 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $8.5M | $5.5M | $5.3M | $5.6M | $5.8M | $6.0M | $5.6M | $7.0M | $6.7M | $5.3M | $4.6M | $3.8M | ||||||
| Additional Paid In Capital | $219.0M | $200.9M | $183.9M | $181.5M | $174.0M | $163.4M | $161.7M | $160.8M | $159.0M | $158.2M | $139.2M | $114.5M | ||||||
| Other Income | $105.3K | $123.1K | $169.2K | $14.3K | $2.6K | $1.00 | $29.9K | $6.0K | $450.00 | |||||||||
| Stock Issued During Period Value Stock Options Exercised | $6.8K | $16.5K | $8.8K | $88.9K | $8.1K | $623.00 | ||||||||||||
| Stock Issued During Period Value Other | $1.8M | $2.4M | $2.7M | $1.0M | $12.0M | |||||||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $345.00 | $597.00 | $460.00 | $1.2K | $6.8K | |||||||||||||
| Stock Issued During Period Value New Issues | $29.6M | $10.0M | $4.6M | $12.0M | ||||||||||||||
| Realized Investment Gains Losses | $67.2K | $39.9K | ||||||||||||||||
| Warrants And Rights Outstanding | $170.4K | $170.4K | ||||||||||||||||
| Stock Issued During Period Shares New Issues | 100.0M |
Most recent annual filing with the SEC: March 27, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.